Sinopharm, Sinovac to supply 550m vaccines to COVAX
Chinese COVID-19 vaccine producers Sinopharm and Sinovac reached advance purchase agreements with the Global Alliance for Vaccines and Immunization (GAVI) to provide as many as 550 million doses of China-made vaccines for the world through the COVAX Facility, a move that would largely help the world tackle the raging Delta variant and build immunity, Chinese experts said.
Sinopharm would provide 60 million doses to GAVI, which is purchasing them on behalf of COVAX, from July through October this year. In addition, GAVI has the option to purchase a further 60 million doses in the fourth quarter of 2021 and 50 million more doses in the first half of 2022, if necessary, GAVI announced Monday. — Source: Global Times
GAVI – Global Alliance for Vaccines and Immunization Founded by Gates Foundation
As a founding partner of Gavi, the Gates Foundation has brought international attention to the cause of immunisation and has made several commitments to Gavi, totalling USD 4.1 billion to-date. In 2000, the foundation made an initial USD 750 million commitment to the Vaccine Fund, which was catalytic in bringing other donors to support vaccine delivery and creating Gavi, the Vaccine Alliance. — Source: GAVI